↓ Skip to main content

Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial

Overview of attention for article published in Alzheimer's Research & Therapy, November 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
2 news outlets
twitter
4 X users

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
Published in
Alzheimer's Research & Therapy, November 2022
DOI 10.1186/s13195-022-01097-2
Pubmed ID
Authors

José Viña, Joaquín Escudero, Miquel Baquero, Mónica Cebrián, Juan Antonio Carbonell-Asíns, José Enrique Muñoz, Encarnación Satorres, Juan Carlos Meléndez, José Ferrer-Rebolleda, Mª del Puig Cózar-Santiago, Jose Manuel Santabárbara-Gómez, Mariona Jové, Reinald Pamplona, Francisco José Tarazona-Santabalbina, Consuelo Borrás

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 8%
Unspecified 3 5%
Student > Master 3 5%
Lecturer 2 3%
Professor 2 3%
Other 6 10%
Unknown 38 64%
Readers by discipline Count As %
Medicine and Dentistry 6 10%
Biochemistry, Genetics and Molecular Biology 4 7%
Unspecified 3 5%
Nursing and Health Professions 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 4 7%
Unknown 38 64%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2022.
All research outputs
#1,788,072
of 24,034,335 outputs
Outputs from Alzheimer's Research & Therapy
#318
of 1,332 outputs
Outputs of similar age
#38,503
of 430,867 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#17
of 54 outputs
Altmetric has tracked 24,034,335 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,332 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.2. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,867 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.